Search research articles
Contact Us
Filters
Showing results (1161-1170 of 1,281) with videos related to
Page
of 129
Sort By:
Advances in Radiation Oncology
|
June 13, 2020
Neurological Death is Common in Patients With EGFR Mutant Non-Small Cell Lung Cancer Diagnosed With Brain Metastases
Matthew Ramotar, Sierra Barnes, Fabio Moraes, et al.
The Oncologist
|
March 11, 2022
Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical Trials
J Connor Wells, Aven Sidhu, Keyue Ding, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 26, 2023
Three-Year Safety, Tolerability, and Health-Related Quality of Life Outcomes of Adjuvant Osimertinib in Patients With Resected Stage IB to IIIA EGFR-Mutated NSCLC: Updated Analysis From the Phase 3 ADAURA Trial
Thomas John, Christian Grohé, Jonathan W Goldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 17, 2023
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy
Nasser Hanna, Frances A Shepherd, Frank V Fossella, et al.
Cancer Treatment and Research Communications
|
November 18, 2023
Presentation and outcomes of KRAS<sup>G12C</sup> mutant non-small cell lung cancer patients with stage IV disease at diagnosis (de novo) versus at recurrence
Niki Esfahanian, Sze Wah Samuel Chan, Luna J Zhan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 24, 2013
Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29
S A Laurie, B J Solomon, L Seymour, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2004
Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy
Nasser Hanna, Frances A Shepherd, Frank V Fossella, et al.
Nucleic Acids Research
|
April 19, 2013
Nucleocapsid protein structures from orthobunyaviruses reveal insight into ribonucleoprotein architecture and RNA polymerization
Antonio Ariza, Sian J Tanner, Cheryl T Walter, et al.
Clinical Lung Cancer
|
November 12, 2018
LACE-Bio: Validation of Predictive and/or Prognostic Immunohistochemistry/Histochemistry-based Biomarkers in Resected Non-small-cell Lung Cancer
Lesley Seymour, Gwénaël Le Teuff, Elisabeth Brambilla, et al.
Cancer Medicine
|
October 26, 2019
Real-world health utility scores and toxicities to tyrosine kinase inhibitors in epidermal growth factor receptor mutated advanced non-small cell lung cancer
Shirley Xue Jiang, Ryan N Walton, Katrina Hueniken, et al.
Page
of 129
Search research articles
Search
Showing results (1161-1170 of 1,281) with videos related to
Sort By:
Page
of 129
Advances in Radiation Oncology
|
June 13, 2020
Neurological Death is Common in Patients With EGFR Mutant Non-Small Cell Lung Cancer Diagnosed With Brain Metastases
Matthew Ramotar, Sierra Barnes, Fabio Moraes, et al.
The Oncologist
|
March 11, 2022
Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical Trials
J Connor Wells, Aven Sidhu, Keyue Ding, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 26, 2023
Three-Year Safety, Tolerability, and Health-Related Quality of Life Outcomes of Adjuvant Osimertinib in Patients With Resected Stage IB to IIIA EGFR-Mutated NSCLC: Updated Analysis From the Phase 3 ADAURA Trial
Thomas John, Christian Grohé, Jonathan W Goldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 17, 2023
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy
Nasser Hanna, Frances A Shepherd, Frank V Fossella, et al.
Cancer Treatment and Research Communications
|
November 18, 2023
Presentation and outcomes of KRAS<sup>G12C</sup> mutant non-small cell lung cancer patients with stage IV disease at diagnosis (de novo) versus at recurrence
Niki Esfahanian, Sze Wah Samuel Chan, Luna J Zhan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 24, 2013
Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29
S A Laurie, B J Solomon, L Seymour, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2004
Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy
Nasser Hanna, Frances A Shepherd, Frank V Fossella, et al.
Nucleic Acids Research
|
April 19, 2013
Nucleocapsid protein structures from orthobunyaviruses reveal insight into ribonucleoprotein architecture and RNA polymerization
Antonio Ariza, Sian J Tanner, Cheryl T Walter, et al.
Clinical Lung Cancer
|
November 12, 2018
LACE-Bio: Validation of Predictive and/or Prognostic Immunohistochemistry/Histochemistry-based Biomarkers in Resected Non-small-cell Lung Cancer
Lesley Seymour, Gwénaël Le Teuff, Elisabeth Brambilla, et al.
Cancer Medicine
|
October 26, 2019
Real-world health utility scores and toxicities to tyrosine kinase inhibitors in epidermal growth factor receptor mutated advanced non-small cell lung cancer
Shirley Xue Jiang, Ryan N Walton, Katrina Hueniken, et al.
Page
of 129